| |
 |
|
CLIROPHTHA IS THE FIRST WORLDWIDE CONTRACT RESEARCH ORGANIZATION (CRO) DEDICATED TO OPHTHALMOLOGY AND SPECIALIZING IN CARRYING OUT PHASE I, PHASE II, PHASE III and PHASE IV CLINICAL TRIALS THROUGHOUT WESTERN AND EASTERN EUROPE, NORTH AFRICA, INDIA, SOUTH ARABIA AND NORTH AMERICA.
|
|
Experience
|
Clirophtha is an independent and private French CRO. The company was established in 1994 by Dr Pierre-Paul Elena who has over 25 years of experience in ophthalmology.
For 13 years now pharmaceutical and biotechnology industries, research institutes and medical device companies of all sizes have chosen to work with us at any level of the clinical drug development process to bring their drug to market faster. Extensive experience, trained staff and an excellent knowledge of the pharmaceutical industry coupled with a unique expertise in ophthalmology are the keys to anticipate the risks, drive the trials to completion efficiently and insure your success.
We have built privileged and well-established relationship with leading professors in ophthalmology, academic centers and investigators to take the best start, choose the best route for your study and increase our effectiveness in recruiting patients.
|
|
Our mission
|
To help you moving a new ocular drug from its conception to marketing approval regardless your point of entry in our range of services by:
- Providing either a full service or customized solutions tailored to your specific needs.
- Producing the most reliable, accurate and high-quality data.
- Reducing the time to perform a study. Clirophtha has built a network of clinicians able to recruit efficiently and to ensure the completion of the trial in time.
|
|
Fields of expertise
|
Glaucoma/Ocular hypertension
Dry eye syndrome
Cataract
Ocular inflammation
Ocular allergy
Ocular infection
Age-related Macular Degeneration (AMD)
Diabetic retinopathy
Contactology
Medical devices
|
|
Location
|
Clirophtha is located in La Gaude, near the international airport of Nice in France.
|
|
